DCVC Bio GP, LLC 13F Holdings · last filed Q2 2022
DCVC Bio GP, LLC reported 1 securities worth $313,000 in its SEC 13F filing for Q2 2022 (period ended 2022-06-30). Top holdings: ABCL (100.00%). Among its top 25 positions this quarter: 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ABCL | AbCellera Biologics, Inc. | $313,000 | 100.00% | 29,411 | Trimmed |
Source: SEC Form 13F filings · as of 2022-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR